for the Period Ended 31 March 2023
Directors report | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 March 2023
Directors
The directors shown below have held office during the whole of the period from
1 April 2022 to 31 March 2023
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Called up share capital not paid: | | | |
Fixed assets | |||
Intangible assets: | | | |
Tangible assets: | 3 | | |
Total fixed assets: | | | |
Current assets | |||
Stocks: | 4 | | |
Debtors: | 5 | | |
Cash at bank and in hand: | | | |
Investments: | | | |
Total current assets: | | | |
Prepayments and accrued income: | | | |
Creditors: amounts falling due within one year: | 6 | ( | ( |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Creditors: amounts falling due after more than one year: | | | |
Provision for liabilities: | ( | ( | |
Accruals and deferred income: | | | |
Total net assets (liabilities): | | | |
Capital and reserves | |||
Called up share capital: | | | |
Share premium account: | | | |
Other reserves: | | | |
Profit and loss account: | | | |
Total Shareholders' funds: | | |
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2023
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Other accounting policies
for the Period Ended 31 March 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 31 March 2023
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 1 April 2022 | | | | |||
Additions | | | | |||
Disposals | ||||||
Revaluations | ||||||
Transfers | ||||||
At 31 March 2023 | | | | |||
Depreciation | ||||||
At 1 April 2022 | | | | |||
Charge for year | | | | |||
On disposals | ||||||
Other adjustments | ||||||
At 31 March 2023 | | | | |||
Net book value | ||||||
At 31 March 2023 | | | | |||
At 31 March 2022 | | | |
for the Period Ended 31 March 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Stocks | | |
Total | | |
for the Period Ended 31 March 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Trade debtors | | |
Other debtors | | |
Total | | |
for the Period Ended 31 March 2023
2023 | 2022 | |
---|---|---|
£ | £ | |
Taxation and social security | | |
Other creditors | | |
Total | | |
HEAL.med continues to support the type-1 diabetes community by creating valuable resources, delivering critical training to Healthcare Professionals (HCP’s) and engaging with key professionals networking events.In 2022/23 HEAL.med delivered projects in collaboration with the Leicester Hospitals Charity, the Leicester Royal Infirmary and many other partners.HEAL.med has invested significantly in developing and improving in education and app for the benefit of the community.The team worked with the children’s diabetes team to pilot a new method of delivering training to school teachers in the local area, with the results being disseminated at ATTD 2023 to the wider diabetes community.HEAL.med attended ISPAD 2022 to present a poster highlighting the valuable work the team has been doing.Our education programme Deapp was awarded with a QiC (Quality in Care) Award, a prestigious and industry recognised achievement, highlighting the impact that the brand has across the UK.The team has strengthened their links with major MedTech companies such as Dexcom and other UK charities, Pop 4 Diabetes, T1 Today and Diabetes UK.
Stakeholders such as HCPs play a key role in development of education for the Deapp Educational programme. This includes sub-groups of specialists that collaborate with the team to ensure the content created is medically accurate and suitable for the community. Engagement and input continues throughout the development process and feedback is continually taken on board.Feedback from the community of users of Deapp education is carefully taken onboard and implemented to ensure continual development and improvement of the services that the team offers.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
7 September 2023
And signed on behalf of the board by:
Name: Mr L R Paxman-Clarke
Status: Director